Filter by Industry
Filter by Topic
A ton of organizations are using (our) reference and affiliation data to sell into healthcare—here's why
Discover why organizations use our healthcare affiliation and reference data to improve healthcare sales, boost targeting, and increase ROI.
Top trends of 2026: New PBM rules will put market access strategies to the test
State regulators ramp up PBM oversight in 2026 cracking down on opaque pricing, rebate structures, and anti-competitive tactics to improve drug…
Top 10 hospital performance metrics you need to know
Explore the top 10 hospital performance metrics you need to know. Learn how KPIs like patient outcomes, readmissions and safety shape healthcare…
How to sell to IDNs & GPOs in a consolidating healthcare market
Navigate healthcare procurement by learning winning strategies for selling to integrated delivery networks (IDNs) & group purchasing organizations…
3 tips for optimizing your medical loss ratio (MLR)
Discover 3 actionable tips to improve your medical loss ratio (MLR). Learn how insurers can reduce costs, stay compliant, and boost health plan…
Top 5 hospitals in 10 major US cities
Discover the largest hospitals in major U.S. cities, including the largest hospitals in NYC, Los Angeles, Chicago, Washington D.C. and more.
Top healthcare trends of 2026: Aging in place is driving innovation in home-based care and technology
See how the desire to age in place is driving innovation in home care, remote monitoring, and smart home technology, enabling seniors to live…
Top healthcare trends of 2026: AI reshapes online search behavior and marketing strategies
Google’s AIOs and LLMs like ChatGPT are shifting search behavior. Here’s what healthcare marketers are doing about it and how you can stay ahead.
Top 5 healthcare payors
Discover the top 5 healthcare payors in 2025. Explore the largest health insurance companies, market share insights, and trends shaping the payer…
Are small-molecule drugs having their big moment?
Small-molecule drugs made up 62% of FDA approvals in 2024. Learn why they dominate drug development and outpace biologics in market share.